Finance

Beta
Lists
XRTX:CVE
XORTX Therapeutics Inc
CA$2.90
+2.84%
(+0.080) 1D
Jun 5, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for XRTX...
Open
CA$2.90
High
CA$2.90
Low
CA$2.90
Mkt. cap
5.02M
Avg. vol.
1.13K
Volume
100.00
52-wk high
CA$9.85
52-wk low
CA$2.42
EPS
-CA$3.68
Beta
0.89
Shares outstanding
1.39M
No. of employees
3
Open
CA$2.90
High
CA$2.90
Low
CA$2.90
Mkt. cap
5.02M
Avg. vol.
1.13K
Volume
100.00
52-wk high
CA$9.85
52-wk low
CA$2.42
EPS
-CA$3.68
Beta
0.89
Shares outstanding
1.39M
No. of employees
3
News stories
From sources across the web
About XORTX Therapeutics Inc
CEOAllen Davidoff
Employees3
Founded2011
HeadquartersCalgary, Alberta, Canada
SectorPharmaceutical industry
Websitexortx.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
186.75K
57.01K
54.86K
33.11K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
469.03K
387.84K
490.98K
614.08K
Operating expense
690.35K
479.35K
579.09K
680.85K
Total operating expenses
690.35K
479.35K
579.09K
680.85K
Operating income
-690.35K
-479.35K
-579.09K
-680.85K
Other non operating income
-50.59K
-160.84K
-14.33K
-135.45K
EBT including unusual items
-717.70K
-649.47K
-590.46K
-808.47K
EBT excluding unusual items
-717.70K
-649.47K
-588.63K
-808.47K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-717.70K
-649.47K
-590.46K
-808.47K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
12.33K
7.20K
3.92K
1.64K
Interest expense
-
-
-
-
Net interest expenses
12.33K
7.20K
3.92K
1.64K
Depreciation and amortization charges
20.84K
22.89K
22.54K
22.38K
EBITDA
-681.82K
-471.99K
-571.99K
-655.00K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more